The prognostic significance of peripheral T-lymphocyte subsets and natural killer cells in patients with colorectal cancer

Hepato-Gastroenterology

Volumn 56, Issue 94-95, 2009, Pages 1310-1315

  Qiu, Haibo ^a,b   Xiao Jun, Wu ^a,b   Zhi Wei, Zhou ^a,b   Gong, Chen ^a,b   Guo Qiang, Wang ^a,b   Li Yi, Zhang ^a,b   Yuan Fang, Li ^a,b   Rajiv Prasad, Keshari ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Colorectal neoplasms; Natural killer cells; Prognosis; T lymphocyte subsets

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CD4 CD8 RATIO; CELLULAR IMMUNITY; COLORECTAL CARCINOMA; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; AGED, 80 AND OVER; CD4-CD8 RATIO; COLORECTAL NEOPLASMS; FEMALE; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; T-LYMPHOCYTE SUBSETS;

EID: 71949083684     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Parkin DM, Bray F, Ferlay J, et al: Global cancer statistics, 2002. CA Cancer J Clin, 2005, 55(2):74-108.
2. Ragnhammar P, Hafstrom L, Nygren P, et al: A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol 2001; 40:282-308. (Pubitemid 32588124)
3. Coca S, Perez-Piqueras J, Martinez D, et al: The prognostic significance of intra tumoral natural killer cells in patients with colorectal carcinoma. Cancer. 1997 Jun 15; 79(12):2320-2328
4. Turnbull RB Jr, Kyle K, Watson FR, Spratt J: Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg. 1967 Sep; 166(3):420-427
5. Dukes CE, Bussey HJR: The spread of rectal cancer and its effect on prognosis. Br J Cancer 1958; 12:309-320
6. Dukes CE: The classification of cancer of the rectum. J Pathol 1932; 35:323-332
7. Zlobec I, Lugli A: Prognostic and predictive factors in colorectal cancer. Postgrad Med J. 2008 Aug; 84(994):403-11.
8. Berghella AM, Pellegrini P, Del Beato T, et al: Prognostic significance of immunological evaluation in colorectal cancer. Cancer Biother Radiopharm. 1997 Aug; 12(4):257-264
9. Kuss I, Haththaway B, Ferris RL, et al: Imbalance in absolute counts of T lymphocyte subsets in patients with head and neck cancer and its relation to disease. Adv Otorhinolaryngol 2005; 62:161-172 (Pubitemid 43264940)
10. Romano F, Uggeri F, Crippa S: Immunodeficiency in different histotypes of radically operabal gastroinstestinal cancer. J Exp Clin Cancer Res 2004; 23(2):195-200. (Pubitemid 38943549)
11. Foss FM: Immunolgic mechanisms of antitumor activity. Semin Oncol. 2002; 29(7):5-11.
12. Heriot AG, Marriott JB, Cookson S: Reduction in cytokine production in colorectal cancer patients association with stage and reversal by resection. Br J Cancer 2000; 82:1009-1012
13. Wolf AM, Wolf D, Steurer M, et al: Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 2003; 9(2):606-612 (Pubitemid 36182591)
14. Lin CY, Bai DJ, Yuan HY, et al: Perioperative cimetidine administration promotes peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: Results of a randomized controlled clinical trial. World J Gastroenterol. 2004 Jan; 10(1):136-142
15. Mazzolini G, Murillo O, Atorrasagasti C, et al: Immunotherapy and immunoescape in colorectal cancer. World J Gastroenterol. 2007 Nov 28; 13(44):5822-5831
16. Ohtani H: Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. Cancer Immun. 2007 Feb 21; 7:4. Review.
17. + T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 1998 Aug 15; 58(16):3491-3494
18. Reynolds J V, Joyce W P, Dolan J, et al: Pathological evidence in support of total mesorectal excision in the management of rectal cancer [J]. Br J Surg, 1996, 83(8):1112-1115. (Pubitemid 26291224)
19. Wang JP, Yang ZL, Wang L, et al: Multi-variate regression analysis of clinicopathological characteristics and prognosis of colorectal cancer. Zhonghua Zhong Liu Za Zhi. 2003 Jan; 25(1):59-61. Chinese.
20. Coussens LM, Werb Z: Inflammation and cancer. Nature. 2002 Dec 19-26; 420(6917):860-867 Review.
21. Nichols PH, Ramsden CW, Ward U, et al: Peri-operative modulation of cellular immunity in patients with colorectal cancer. Clin Exp Immunol. 1993 Oct; 94(1):4-10.
22. Mizoguchi H, O'Shea JJ, Longo DL, et al: Alterations in signal transduction molecules in T lymphocytes from tumor bearing mice. Science (Washington DC), 258:1795-1798, 1992. (Pubitemid 23087347)
23. Finke JH, Zea AH, Stanley J, et al: Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma . Cancer Res., 53:5613-5616, 1993. (Pubitemid 23360259)
24. Miescher, S, Stoeck, M, Qiao, L, et al: Proliferative and cytolytic potentials of purified human tumor-infiltrating T lymphocytes. Impaired response to mitogen-driven stimulation despite T-cell receptor expression. Int. J. Cancer, 42:659-666, 1988.
25. Vitolo D, Zerbe T, Kanbour A, et al: Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer. Int J Cancer. 1992 Jun 19; 51(4):573-580
26. + ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells. Cancer Immunol Immunother. 2003 Jul; 52(7):423-428 Epub 2003 Apr 15.
27. Rushfeldt C, Sveinbjornsson B, Seljelid R, et al: Early events of hepatic metastasis formation in mice: role of Kupffer and NK-cells in natural and interferon-gamma-stimulated defense. J Surg Res 1999; 82:209-215. (Pubitemid 29394125)
28. Pilla L, Squarcina P, Coppa J, et al: Natural killer and NK-Like T-cell activation in colorectal carcinoma patients treated with autologous tumor-derived heat shock protein 96. Cancer Res. 2005 May 1; 65(9):3942-3949
29. Tartter PI, Steinberg B, Barron DM, et al: The prognostic significance of natural killer cytotoxicity in patients with colorectal cancer. Arch Surg. 1987 Nov; 122(11):1264-1268